Product Program year 2024 Source: CMS Open Payments

Allure Quadra

Device Cardiac Rhythm Management

PDI 05414734507912

Open in the dashboard

General payments

$108,736

1,046 payments

Research payments

$0

0 payments

Through program year 2024, $108,736 in general payments and $0 in research payments were reported against Allure Quadra (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $4,730 101
2023 General $21,833 188
2022 General $82,172 757

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $108,736 1,046 payments
Top recipients General payments · program year 2024
  1. Zachary Estep Internal Medicine · Browns Mills, NJ $382 8% · 2 payments
  2. James Barnett Cardiovascular Disease · Midland, TX $219 5% · 4 payments
  3. Raffaele Corbisiero Clinical Cardiac Electrophysiology · Browns Mills, NJ $191 4% · 1 payment
  4. Stephen Crawford Nuclear Cardiology · Voorhees, NJ $191 4% · 1 payment
  5. Gin Chang Internal Medicine · Roslyn, NY $191 4% · 1 payment

The top 5 of 85 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Internal Medicine $1,498 32% · 7 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $1,464 31% · 32 practitioners
  3. Cardiovascular Disease Internal Medicine $749 16% · 18 practitioners
  4. Interventional Cardiology Internal Medicine $273 6% · 11 practitioners
  5. Nuclear Cardiology Nuclear Medicine $191 4% · 1 practitioner

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $1,321 28% · 18 recipients
  2. Pennsylvania $717 15% · 9 recipients
  3. New York $571 12% · 6 recipients
  4. New Jersey $403 9% · 3 recipients
  5. South Carolina $396 8% · 4 recipients

The top 5 of 23 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

1,046 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record